Cargando…
Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1)
Docetaxel has been used as first-line chemotherapy in advanced non-small cell lung carcinoma (NSCLC), but further extensive and effective application is prevented by drug resistance. MicroRNAs (miRNAs) have recently been identified as important posttranscriptional regulators, which are involved in v...
Autores principales: | Rui, Wang, Bing, Feng, Hai-Zhu, Song, Wei, De, Long-Bang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837589/ https://www.ncbi.nlm.nih.gov/pubmed/19900214 http://dx.doi.org/10.1111/j.1582-4934.2009.00964.x |
Ejemplares similares
-
Computational identification of microRNA gene loci and precursor microRNA sequences in CHO cell lines
por: Hackl, Matthias, et al.
Publicado: (2012) -
A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment
por: Wachters, F M, et al.
Publicado: (2005) -
Combined Micro-PET/Micro-CT Imaging of Lung Tumours in SPC-raf and SPC-myc Transgenic Mice
por: Rodt, Thomas, et al.
Publicado: (2012) -
MicroRNA-650 Was a Prognostic Factor in Human Lung Adenocarcinoma and Confers the Docetaxel Chemoresistance of Lung Adenocarcinoma Cells via Regulating Bcl-2/Bax Expression
por: Huang, Jia-Yuan, et al.
Publicado: (2013) -
Genome‐wide identification of urinary cell‐free microRNAs for non‐invasive detection of bladder cancer
por: Juracek, Jaroslav, et al.
Publicado: (2018)